HIMS 8-K: Smart Summary
76% reductionHims & Hers Health, Inc. held its Annual Meeting of Stockholders on June 11, 2026, at which stockholders voted on three proposals: the election of nine directors, ratification of KPMG LLP as independent auditor, and advisory approval of executive compensation.
Item 5.07: Submission of Matters to a Vote of Security Holders
Director Elections
- Andrew Dudum — 1,504,939,830 for / 13,028,642 against (99.15% approval)
- Kofi Amoo-Gottfried — 1,517,440,666 for / 527,806 against (99.97% approval)
- Deborah Autor — 1,516,370,269 for / 1,598,203 against (99.89% approval)
- Delos Cosgrove, M.D. — 1,516,949,085 for / 1,019,387 against (99.93% approval)
- Anja Manuel — 1,516,973,593 for / 994,879 against (99.93% approval)
- Christopher Payne — 1,508,808,309 for / 9,160,163 against (99.40% approval)
- Andrea Perez — 1,516,871,986 for / 1,096,486 against (99.93% approval)
- Kare Schultz — 1,516,971,244 for / 997,228 against (99.93% approval)
- David Wells — 1,501,758,393 for / 16,210,079 against (98.93% approval)
Management Proposals
- Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 — 1,591,246,881 for / 516,386 against / 433,438 abstain (99.97% approval) — passed
- Advisory approval of executive compensation — 1,506,477,171 for / 11,181,420 against / 309,881 abstain (99.27% approval) — passed
§ MORE SUMMARIES
More HIMS Smart Summaries
Other filings for Hims & Hers Health, Inc. with a Smart Summary.
8-K$HIMSHims & Hers Health, Inc.Smart Summary
8-K Filing
Amends $200M revolving credit facility to support Eucalyptus acquisition
8-K$HIMSHims & Hers Health, Inc.Smart Summary
8-K Filing
Issues $402.5M convertible notes due 2032
8-K$HIMSHims & Hers Health, Inc.Smart Summary
8-K Filing
Prices $350M convertible notes for international expansion and Eucalyptus
8-K$HIMSHims & Hers Health, Inc.Smart Summary
8-K Filing
Q2 2026 earnings results
Never miss a HIMS filing
Get real-time email alerts when HIMS files with the SEC.